A Double-Blind, Placebo-Controlled Study With Open-Label Follow-Up To Determine the Safety and Efficacy of r-HuEPO in AIDS Patients With Anemia Induced by Their Disease and AZT Therapy

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused Both by Their Disease and by AZT (Zidovudine, an Antiviral Drug) Given as Treatment for Their Disease

NCT00270010 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in AIDS (Acquired Immunodeficiency Syndrome) Patients With Anemia Caused by the Disease and by Zidovudine (AZT) Therapy

NCT00270270 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo for the Treatment of Anemia in Patients With Acquired Immunodeficiency Syndrome (AIDS) Who Are Receiving Zidovudine (AZT) Therapy

NCT00270283 ·Status: COMPLETED ·Phase: PHASE2

Treatment Program for Anemia in AIDS Patients

NCT00002022 ·Status: COMPLETED ·Phase: NA

An Open-Label Study to Evaluate the Effect of Every Other Week PROCRIT� (Epoetin Alfa) Dosing (40,000-60,000 Units) On Maintaining Quality of Life and Target Hemoglobin Levels in Anemic HIV-Infected Patients (CHAMPS II)

NCT00317902 ·Status: COMPLETED ·Phase: PHASE4

Hemoglobin Optimization to Prevent Transfusion and Adverse Events in Perioperative Patients With Iron Restricted Anemia

NCT03528564 ·Status: TERMINATED ·Phase: PHASE2

A Study to Evaluate the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Facilitating the Presurgical Collection of Blood to be Used for Self-donation During Surgery on the Spine, Hip, or Knee.

NCT00270140 ·Status: COMPLETED ·Phase: PHASE3

Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection

NCT00000587 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety and Efficacy of Epoetin Alfa Versus Placebo to Reduce the Need for Blood Transfusions and Reduce the Occurrence of Severe Anemia During the Time Period Surrounding Total Hip Replacement Surgery

NCT00269958 ·Status: COMPLETED ·Phase: PHASE2

A Study to Evaluate the Safety of Epoetin Alfa and Its Effectiveness in Facilitating the Presurgical Collection of Blood From Anemic Patients for Possible Self-transfusion During and After Scheduled Joint Surgery.

NCT00270062 ·Status: COMPLETED ·Phase: PHASE3

A Study to Evaluate the Effectiveness and Safety of Epoetin Alfa During the Period When One is Donating One's Own Blood Before Surgery.

NCT00270179 ·Status: COMPLETED ·Phase: PHASE3

A Study to Determine the Safety and Effectiveness of Epoetin Alfa Versus Placebo in Patients With Persistent Anemia Caused by Advanced Cancer

NCT00269984 ·Status: COMPLETED ·Phase: PHASE2

Erythropoietin Therapy in Patients With Chronic Renal Failure: A Study of Time Dependent Activity

NCT00744445 ·Status: COMPLETED ·Phase: PHASE2

Erythropoietin (Epo) and Venofer Trial After Autologous Hematopoietic Stem Cell Transplantation (HSCT)

NCT00557817 ·Status: COMPLETED ·Phase: PHASE2/PHASE3

Effects of Intravenous Injection of Erythropoietin on Hepcidin Pharmacokinetics in Healthy Volunteers

NCT00687518 ·Status: UNKNOWN ·Phase: NA

An Open-label Trial to Determine Increased Red Blood Cell Production in Subjects With Anemia of Chronic Disease

NCT01846689 ·Status: UNKNOWN ·Phase: PHASE3

A Phase 3, Long-Term Safety Study of Intravenous Epoetin Hospira in Patients With Chronic Renal Failure Requiring Hemodialysis and Receiving Epoetin Maintenance Treatment. AiME - Anemia Management With Epoetin

NCT01628107 ·Status: COMPLETED ·Phase: PHASE3

Efficacy and Safety of Peginesatide Injection for the Maintenance Treatment of Anemia in Peritoneal Dialysis Participants Previously Treated With Epoetin.

NCT00752791 ·Status: COMPLETED ·Phase: PHASE2

Study to Assess S303 RBCs and Evaluate Safety and Efficacy in Patients Requiring Transfusion Support of Acute Anemia

NCT01716923 ·Status: COMPLETED ·Phase: PHASE3

Intravenous (IV) Iron vs. No Iron as the Treatment of Anemia in Cancer Patients Undergoing Chemotherapy and Erythropoietin Therapy

NCT00236951 ·Status: COMPLETED ·Phase: PHASE3

Randomized, Controlled, Double-blind Multicenter Safety Study to Evaluate the Safety and Immunogenicity of Subcutaneous EPO HEXAL vs. ERYPO® in the Treatment of Anemia Associated With Chronic Renal Insufficiency in Predialysis Patients

NCT00701714 ·Status: TERMINATED ·Phase: PHASE3

Intravenous Treatment of Anemia in Pregnancy

NCT03317210 ·Status: COMPLETED ·Phase: PHASE4

A Study to Evaluate the Effectiveness of Aranesp® for Cancer Patients With Anemia

NCT00117039 ·Status: COMPLETED ·Phase: PHASE4

Intravaneous Iron(1000 mg Low Molecular Weight Iron Dextran Over 60 Minutes) for Pregnant Women

NCT02038023 ·Status: COMPLETED ·Phase: PHASE2

Hydroxyurea and EPO in Sickle Cell Disease

NCT05451940 ·Status: COMPLETED ·Phase: PHASE1/PHASE2